Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Never Use Damaged Sieves or Mesh During Granulation in GMP

Posted on May 23, 2025 By digi

Never Use Damaged Sieves or Mesh During Granulation in GMP

Damaged Sieves Must Not Be Used in Granulation Processes

Remember: Inspect all sieves and meshes before use—damaged screens compromise granule size, uniformity, and product safety.

Why This Matters in GMP

Sieves are used during granulation to control particle size distribution and ensure blend uniformity. A torn or distorted sieve can result in oversized or undersized particles, affecting tablet hardness, dissolution, and bioavailability. Worse, metal fragments or loose wires may detach and contaminate the batch, posing serious safety hazards. Continued use of damaged sieves reflects poor equipment management and lack of preventive maintenance. GMP manufacturing requires that only qualified, intact equipment be used at every stage of processing. Regular inspections of mesh screens are essential to product quality, equipment longevity, and patient safety.

Also Read:  How to Prevent Counterfeit Pharmaceuticals in the Supply Chain Using GMP

Regulatory and Compliance Implications

FDA 21 CFR Part 211.65 and 211.67 require proper construction, maintenance, and cleaning of equipment. WHO GMP and Schedule M stress inspection and control of manufacturing tools and their impact on product quality. EU GMP Chapter 5 and 3 also require equipment to be suitable for intended use and maintained in good condition. Regulatory auditors frequently inspect equipment logs and check for visual signs of screen damage. Use of damaged sieves can trigger recalls, product rejection, and compliance observations for poor maintenance practices.

Implementation Best Practices

  • Inspect sieves before and after use under adequate lighting conditions.
  • Maintain a sieve integrity checklist and record verification before batch startup.
  • Assign unique ID numbers to sieves and link them to usage logs and cleaning records.
  • Train operators to recognize mesh damage and quarantine any compromised tools immediately.
  • Include sieve inspections in equipment qualification and periodic maintenance SOPs.
Also Read:  Never Discard Rejected Materials in General Trash Bins

Regulatory References

  • FDA 21 CFR Part 211.65 – Equipment Construction
  • FDA 21 CFR Part 211.67 – Equipment Cleaning and Maintenance
  • WHO GMP – Equipment Requirements
  • Schedule M – Equipment Inspection and Maintenance
  • EU GMP Chapter 5 – Production
GMP Tips Tags:audit readiness, contamination risk, equipment inspection, Equipment qualification, FDA 21 CFR Part 211, GMP compliance, granulation sieves, manufacturing deviation, mesh integrity, particle size control, quality assurance, Schedule M, screen damage, WHO GMP

Post navigation

Previous Post: The Shift Towards Outcome-Based GMP Inspections
Next Post: Integrating GMP Inspection Results into Public Health Decision-Making

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Do Not Leave Batch Records in Uncontrolled Office Areas

    Do Not Leave Batch Records… Read more

GMP Tips

  • Do Not Leave Batch Records in Uncontrolled Office Areas
  • Implement UV Sterilization Protocols in GMP Change Rooms
  • Do Not Allow Incomplete Documentation During GMP Batch Record Review
  • Assign Identification Numbers to All Cleaning Tools for Traceability
  • Never Use Damaged Sieves or Mesh During Granulation in GMP
  • Conduct Alarm Challenge Tests to Validate Critical GMP System Responses
  • Do Not Ignore Elevated Noise Levels in GMP Classified Areas
  • Cross-Verify Certificate of Analysis (COA) With Raw Data for GMP Assurance
  • Do Not Store Chemicals Without Material Safety Data Sheets (MSDS)
  • Perform Visual Inspection of Vials Using Qualified Lighting Conditions

More about GMP Tips :

  • Do Not Include Unrelated Documents in GMP Production Records
  • Do Not Store Clean and Dirty Garments Together in GMP Facilities
  • Never Replace Approved SOPs with Verbal Instructions in GMP
  • Implement Controlled Access to Data Entry Terminals in GMP Areas
  • Follow Hold Time Studies to Ensure Product Stability and Safety
  • Monitor Utility Systems Like Water and Compressed Air for GMP Quality
  • Never Use Photocopies as Originals for GMP Quality Documents
  • Never Touch Sterile Surfaces Without Wearing Gloves
  • Maintain Access Logs for Electronic GMP Systems to Ensure Accountability
  • Conduct Routine Gown Integrity Checks in GMP Cleanrooms
  • Verify Integrity of Tamper-Evident Seals During Packaging
  • Perform Visual Inspection of Vials Using Qualified Lighting Conditions
  • Never Skip Microbial Monitoring in Critical GMP Zones
  • Implement UV Sterilization Protocols in GMP Change Rooms
  • Calibrate Laboratory Balances Regularly Using Certified Weights

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme